Analysis: Lawmakers are trying to prove they're serious about lowering drug costs
But how much drug makers should actually worry remains to be seen.
AHH: The Trump administration has appealed a pair of federal court rulings that blocked programs in Kentucky and Arkansas requiring able-bodied Medicaid beneficiaries to work in order to qualify for coverage. Kaiser Health News conducted an analysis of data from the University of Michigan and found hundreds of suicides by older adults every year may be related to long-term care. “Thousands more people may be at risk in those settings, where up to a third of residents report suicidal thoughts, research shows,”These suicides are raising questions about the facilities where they're taking place.
“Found in hospitals and long-term care facilities, it can quickly lead to death in patients who have weakened immune systems or other underlying serious medical problems,” Kaitlyn and Lindy write. “More than one in three patients with an invasive infection of the fungus has died, the CDC said.”Sen. Bernie Sanders introduces the Medicare for All Act of 2019, on Capitol Hill.
In a statement, White House press secretary Sarah Sanders panned the proposal, instead touting a plan the president has vowed to produce. “McConnell has not yet said whether he’ll bring the health care bill, introduced Wednesday, up for a vote, but some Republicans are hopeful he will,” Politico’s Marianne Levine, Adam Cancryn and Alice Miranda Ollstein report. “I think it deserves a full debate and a vote and see how many Democrats who are co-sponsors actually support it,” Sen. John Barrasso told them.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Analysis | The Health 202: Drug maker accuses FDA of hampering its medication for opioid treatmentThe Health 202: Drug maker accuses FDA of hampering its medication for opioid treatment
Consulte Mais informação »
Analysis | The Health 202: Pharmacy middlemen are under scrutiny for pushing up drug pricesAnalysis: Pharmacy middlemen are under scrutiny for pushing up drug prices
Consulte Mais informação »
Analysis | The Technology 202: Lawmakers plan to ratchet up pressure on tech companies' content moderation practicesThe Technology 202: Lawmakers plan to ratchet up pressure on tech companies' content moderation practices
Consulte Mais informação »
Analysis | The Technology 202: Lawmakers missed a chance to actually grill Silicon Valley on content moderationAnalysis: Lawmakers missed a chance to actually grill Silicon Valley on content moderation
Consulte Mais informação »
Analysis | The Health 202: HHS says it can't place unaccompanied migrant children with sponsors as fast as they're coming inThe Health 202: HHS says it can't place unaccompanied migrant children with sponsors as fast as they're coming in
Consulte Mais informação »
Analysis | The Energy 202: Young people take center stage at new House climate committee's first hearingThe Energy 202: Young people take center stage at new House climate committee's first hearing
Consulte Mais informação »
Analysis | The Cybersecurity 202: Nielsen departure could deal a blow to Trump administration's cybersecurity effortsAnalysis: Nielsen departure could deal a blow to Trump administration's cybersecurity efforts
Consulte Mais informação »
Analysis | The Technology 202: Local news is the next battleground as Congress eyes Big Tech's powerUnder current antitrust laws, news publishers are barred from working together as they seek deals with tech platforms.
Consulte Mais informação »
Analysis | The Daily 202: Mnuchin gets riled but Barr keeps his cool in pugnacious congressional appearancesAnalysis: Mnuchin gets riled but Barr keeps his cool in pugnacious congressional appearances
Consulte Mais informação »
Analysis | The Health 202: Bernie Sanders is about to roll out an even more expansive Medicare-for-all billAnalysis: Bernie Sanders is about to roll out an even more expansive Medicare-for-all bill
Consulte Mais informação »